rs9277555

Variant names:

• chr6-33087828-G-A
• rs9277555
• NM_002121.6:c.*1294G>A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_Strong BA1

The NM_002121.6(HLA-DPB1):​c.*1294G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.326 in 152,066 control chromosomes in the GnomAD database, including 9,115 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency: Genomes: 𝑓 0.33 (9115 hom., cov: 32)
• Consequence: HLA-DPB1 NM_002121.6 3_prime_UTR
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: -1.47
• Publications: 34 publications found

Genes affected

HLA-DPB1 (HGNC:4940): (major histocompatibility complex, class II, DP beta 1) HLA-DPB belongs to the HLA class II beta chain paralogues. This class II molecule is a heterodimer consisting of an alpha (DPA) and a beta chain (DPB), both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The beta chain is approximately 26-28 kDa and its gene contains 6 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, exon 4 encodes the transmembrane domain and exon 5 encodes the cytoplasmic tail. Within the DP molecule both the alpha chain and the beta chain contain the polymorphisms specifying the peptide binding specificities, resulting in up to 4 different molecules. [provided by RefSeq, Jul 2008]

ACMG classification

Our verdict: Benign. The variant received -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.94).
• BA1: GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.548 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
HLA-DPB1	NM_002121.6	c.*1294G>A		3_prime_UTR_variant	Exon 6 of 6	ENST00000418931.7	NP_002112.3

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
HLA-DPB1	ENST00000418931.7	c.*1294G>A		3_prime_UTR_variant	Exon 6 of 6	6	NM_002121.6	ENSP00000408146.2
HLA-DPB1	ENST00000714457.1	n.3879G>A		non_coding_transcript_exon_variant	Exon 7 of 7
HLA-DPB1	ENST00000428835.6	c.*1294G>A		3_prime_UTR_variant	Exon 6 of 6	6		ENSP00000412654.2

Frequencies

GnomAD3 genomes AF: 0.326 AC: 49586 AN: 151948 Hom.: 9094 Cov.: 32

Gnomad AFR AF: 0.475

Gnomad AMI AF: 0.133

Gnomad AMR AF: 0.254

Gnomad ASJ AF: 0.156

Gnomad EAS AF: 0.565

Gnomad SAS AF: 0.262

Gnomad FIN AF: 0.249

Gnomad MID AF: 0.215

Gnomad NFE AF: 0.263

Gnomad OTH AF: 0.314

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.326 AC: 49635 AN: 152066 Hom.: 9115 Cov.: 32 AF XY: 0.322 AC XY: 23902 AN XY: 74342

African (AFR) AF: 0.475 AC: 19662 AN: 41434

American (AMR) AF: 0.254 AC: 3883 AN: 15290

Ashkenazi Jewish (ASJ) AF: 0.156 AC: 539 AN: 3466

East Asian (EAS) AF: 0.565 AC: 2921 AN: 5168

South Asian (SAS) AF: 0.260 AC: 1252 AN: 4822

European-Finnish (FIN) AF: 0.249 AC: 2637 AN: 10588

Middle Eastern (MID) AF: 0.214 AC: 63 AN: 294

European-Non Finnish (NFE) AF: 0.263 AC: 17874 AN: 67982

Other (OTH) AF: 0.323 AC: 683 AN: 2112

Alfa AF: 0.291 Hom.: 18031

Bravo AF: 0.331

Asia WGS AF: 0.395 AC: 1372 AN: 3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.94
CADD	Benign	0.66
DANN	Benign	0.33
PhyloP100		-1.5

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs9277555; hg19: chr6-33055605;